Anti-Tumor Activity of Selective Inhibitor of Nuclear Export (SINE) Compounds, Is Enhanced in Non-Hodgkin Lymphoma Through Combination With mTOR Inhibitor and Dexamethasone

Cancer Letters - Ireland
doi 10.1016/j.canlet.2016.09.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma

Cancer Discovery
Oncology
2017English

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185

PLoS ONE
Multidisciplinary
2015English

Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity

Oncotarget
Oncology
2017English

Selective Inhibitors of Nuclear Export (SINE)– A Novel Class of Anti-Cancer Agents

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2014English

Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces RSV Replication in Vitro

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Combination Treatment With Doxorubicin and microRNA-21 Inhibitor Synergistically Augments Anticancer Activity Through Upregulation of Tumor Suppressing Genes

International Journal of Oncology
Cancer ResearchOncology
2015English

Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

PLoS ONE
Multidisciplinary
2014English

The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy